Navigation Links
CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase
Date:10/9/2008

r of 2008 and positive operating cash flow for our full 2009 fiscal year. We'll continue to make judicious investments that drive increased revenue growth and help establish ICG in the treatment guidelines for heart failure and hypertension in the coming years."

Conference Call Information

Michael K. Perry, Chief Executive Officer, and Steve P. Loomis, Chief Financial Officer, will host a summary of CardioDynamics' third quarter 2008 results in a conference call today, Thursday, October 9, 2008, at 4:30 p.m. (EDT). To access the conference call, dial 800-346-7359 (Code 7784). International participants can call 973-528-0008 (Code 7784). A replay of the call will be available for one month following the call at 800-332-6854 (Code 7784). The international replay number is 973-528-0005 (Code 7784). The Internet webcast can be accessed through the Investor Relations section of the Company's website at http://www.cdic.com or at http://tinyurl.com/4dknlk.

About CardioDynamics

CardioDynamics International Corporation (Nasdaq: CDIC), the ICG Company, is the innovator and leader of an important medical technology called impedance cardiography (ICG). The Company develops, manufactures and markets noninvasive ICG products and ICG electrodes. The Company's ICG Systems are being used by physicians around the world to help battle the number one killer of men and women--cardiovascular disease. Partners include GE Healthcare, Philips Medical Systems and Mindray. For additional information, please refer to the Company's Web site at http://www.cdic.com.

Forward-Looking (Safe Harbor
'/>"/>

SOURCE CardioDynamics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. CardioDynamics BioZ(R) ICG Technology Integrates with General Electric Healthcares Centricity(R) Electronic Medical Record (EMR) System
2. CardioDynamics Shareholders Approve One-for-Seven Reverse Split of Companys Common Stock and Trading in Post-split Shares Begins May 9, 2008
3. CardioDynamics Receives Nasdaq Letter of Non-Compliance With Minimum Bid Price Requirement
4. CardioDynamics BioZ(R) ICG Technology Featured in American College of Cardiology (ACC) Audio Series
5. CardioDynamics Ranked in Deloittes Technology Fast 50 Program for San Diego
6. CardioDynamics Receives FDA 510(k) Clearance for Innovative Clinical Parameters and Electronic Medical Record Compatibility
7. CardioDynamics Provides 2007 Shareholder Meeting Update
8. Paper in Cell Cycle Reports Alfacells ONCONASE(R) Targets siRNA
9. Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics
10. TorreyPines Therapeutics Reports Successful End-of-Phase II Meeting With FDA for Tezampanel
11. Corgenix Reports Fiscal 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... The third Medical Innovation Impact Index ... , in particular, drug/device combinations. The current system received a score of 0 (range ... Patient Centered Innovation (iPCI) of Fairleigh Dickinson University’s ( FDU ) Rothman Institute ...
(Date:7/29/2015)... ... July 29, 2015 , ... Finding gooey or crusty material in ... Although there are a considerable number of terms in popular use to describe it, ... is a mixture of mucus, blood cells, skin cells and dust, but until now ...
(Date:7/29/2015)... ... July 29, 2015 , ... Costello served as Lead Levee ... to protect the Orange County, Texas area from future storm surge flooding, such as ... determining several potential levee alignment alternatives for providing protection, Costello also balanced socio-economic and ...
(Date:7/29/2015)... ... July 29, 2015 , ... Nearly everyone has heard of ... few people realize that a rich source of these cells is teeth—baby teeth that ... that need to be pulled to make room for braces. These potent stem ...
Breaking Biology Technology:Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 2Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 3What Are ‘Eye Crusties’ Made Of? uBiome Invites Citizen Scientists to Find Out 2What Are ‘Eye Crusties’ Made Of? uBiome Invites Citizen Scientists to Find Out 3What Are ‘Eye Crusties’ Made Of? uBiome Invites Citizen Scientists to Find Out 4Preventing Storm Surge Flooding in Houston 2Advanced Oral and Maxillofacial Surgery (AOMS) in Elmhurst, IL Partners with Provia Labs to make Store-A-Tooth™ Dental Stem Cell Banking Available to their Patients 2
... Hong Kong-based subsidiary Pangu BioPharmaSAN DIEGO, March 10 ... discovery and development of an entirely new class of ... announced that Dr. James Cai has joined the Company ... Pharma and President of Pangu BioPharma, a fully owned ...
... Zimmer Holdings, Inc. (NYSE: ZMH ; ... the 29th Annual Cowen and Company Health Care Conference ... a.m. Eastern Time.A live webcast of the presentation can ... http://investor.zimmer.com . The webcast will be archived for ...
... Reduce the Risks of DVT to Mark U.S. House ... The Coalition to Prevent DVT today announced the launch ... about deep-vein thrombosis (DVT) and to encourage dialogue between ... condition. A customized recreational vehicle will visit hospitals ...
Cached Biology Technology:Dr. James Cai Joins aTyr Pharma to Drive Clinical Development in Asia 2Dr. James Cai Joins aTyr Pharma to Drive Clinical Development in Asia 3The Coalition to Prevent Deep-Vein Thrombosis (DVT) RV Tour Takes to the Road to Educate the Nation About the Importance of DVT Risk Assessment 2The Coalition to Prevent Deep-Vein Thrombosis (DVT) RV Tour Takes to the Road to Educate the Nation About the Importance of DVT Risk Assessment 3The Coalition to Prevent Deep-Vein Thrombosis (DVT) RV Tour Takes to the Road to Educate the Nation About the Importance of DVT Risk Assessment 4The Coalition to Prevent Deep-Vein Thrombosis (DVT) RV Tour Takes to the Road to Educate the Nation About the Importance of DVT Risk Assessment 5
(Date:7/9/2015)...  Unchained Labs just can,t get enough biologics ... Nano. Avid Nano designs, develops and manufactures highly ... Also today, Unchained Labs UNcaged the pUNk, ... protein sizing system. The pUNk is a high-performance ... size distribution, aggregation population and molecular weight. Its ...
(Date:7/8/2015)...  Trovagene, Inc. (NASDAQ: TROV ), a ... launch of a study that aims to determine ... technology for predicting response to treatment in advanced ... the novel immunotherapy agents Yervoy® (ipilumumab), a CTLA-4 ... 50-patient study will be led by researchers at ...
(Date:7/7/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") a ... a revised version of one of its first 30 second commercials ... in New York , Chicago ... Francisco metro areas.    , , , ... all the cards in your wallet and keep your identity secure. ...
Breaking Biology News(10 mins):Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
... Could straw houses be the buildings of the future? ... testing this summer by constructing a "BaleHaus" made of prefabricated ... And people around the world will be able to watch ... www.bath.ac.uk/features/balehaus/ ,- part of a site which will also ...
... Fla. (July 27, 2009) An Italian research team, ... (18:4), which is now available on-line without charge ... derived from human placenta may ultimately play a role ... fibrosis and fibrotic diseases caused by tuberculosis, chemical exposure, ...
... Ph.D., from the Louisiana Universities Marine Consortium (LUMCON), found the ... be smaller than forecasted, measuring 3,000 square miles. However the ... the sea floor, was severe where it did occur, extending ... Earlier this summer, NOAA-sponsored forecast models developed by R. ...
Cached Biology News:University has grand designs to build a house of straw 2University has grand designs to build a house of straw 3Placenta-derived stem cells may help sufferers of lung diseases 2Smaller than expected, but severe, dead zone in Gulf of Mexico 2
... Application: The simple three step procedure (PCR, ... be completed in one day. The typical ... than 80%. , Features and Benefits: , ... cloned into any expression vector , High ...
Designed for use with all 96-well SPRI reagent kits. Used with round bottom 96-well microplates, and 96-well thermal cycling plates....
... can be used with all ... for stacking of covered plates ... use with automated systems ... non-ridged, are available for use ...
... is a new product number, ... product number. If showing no ... the old Sigma-Aldrich number (Z71,667-7) ... assistance. ID clarifier: barcoded, bulk ...
Biology Products: